| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 01/16/2014 | US20140018344 Azaindole derivatives |
| 01/16/2014 | US20140018341 Method of inhibiting tau phosphorylation |
| 01/16/2014 | US20140018313 Antiviral compounds |
| 01/16/2014 | CA2876449A1 Aryl sultam derivatives as rorc modulators |
| 01/16/2014 | CA2876370A1 Compounds and methods for treating hiv |
| 01/15/2014 | EP2683723A1 Spirocyclic isoxazoline derivatives as antiparasitic agents |
| 01/15/2014 | EP2683706A1 Oxaspiro [2.5]octane derivatives and analogs |
| 01/15/2014 | EP2683244A1 Heterocyclic modulators of lipid synthesis |
| 01/15/2014 | CN103517907A Spirocyclic isoxazoline derivatives as antiparasitic agents |
| 01/15/2014 | CN103517898A Novel 3-hydroxyisothiazole 1-oxide derivative |
| 01/15/2014 | CN103509036A Novel fused ring compound and organic light-emitting device including the same |
| 01/15/2014 | CN103509030A Camptothecin compounds, and preparation and applications thereof |
| 01/15/2014 | CN103509029A Phenanthroquinolizidine alkaloid derivatives and salts thereof, and preparation, anti-plant virus activity and anti-cancer activity of phenanthroquinolizidine alkaloid derivatives and salts thereof |
| 01/15/2014 | CN103508981A New piperazine derivative and medical applications |
| 01/14/2014 | US8629272 Tricyclic pyrimidine derivatives as wnt antagonists |
| 01/14/2014 | US8629084 Iodine-phenyl-substituted cyclic cetoenols |
| 01/14/2014 | US8628975 Methods and kits using extended rhodamine dyes |
| 01/09/2014 | WO2014008285A1 Inhibitors of hepatitis c virus |
| 01/09/2014 | WO2014008223A2 Fatty acid synthase inhibitors |
| 01/09/2014 | WO2014008214A1 Biaryl-containing compounds as inverse agonists of ror-gamma receptors |
| 01/09/2014 | WO2014005421A1 Benzodioxole derivative and preparation method and use thereof |
| 01/09/2014 | WO2012135944A9 Protein kinase inhibitors |
| 01/09/2014 | US20140012001 Novel polymorphic form of rifaximin and process for its preparation |
| 01/09/2014 | US20140011833 Camptothecin derivatives having anti-tumor activity |
| 01/09/2014 | US20140011796 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
| 01/09/2014 | US20140011775 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 01/09/2014 | US20140011770 Compositions and methods for inhibition of the jak pathway |
| 01/09/2014 | US20140011764 Anti-Viral Pyrimidine Nucleoside Analogues |
| 01/09/2014 | US20140010784 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/09/2014 | CA2878000A1 Benzodioxole derivative and preparation method and use thereof |
| 01/09/2014 | CA2877005A1 Inhibitors of hepatitis c virus |
| 01/09/2014 | CA2876689A1 Substituted tricyclic compounds as fgfr inhibitors |
| 01/08/2014 | EP2681194A1 3-amino-pyridines as gpbar1 agonists |
| 01/08/2014 | EP2681191A1 2-acyloxy-pyrrolin-4-ones |
| 01/08/2014 | CN103502211A Electrophilic alkylating reagents, preparation and use thereof |
| 01/08/2014 | CN103497193A Derivative with 1,2,4-triazine skeleton structure and synthesis method thereof |
| 01/07/2014 | US8623890 Nematocidal sulfonamides |
| 01/07/2014 | US8623869 Compounds useful as inhibitors of ATR kinase |
| 01/03/2014 | WO2014003694A1 Synthesis of thiosemicarbazides and triazoles derived from etodolac |
| 01/03/2014 | WO2014003693A1 Etodolac derivatives as hcv ns5b polymerase inhibitors |
| 01/03/2014 | WO2014001464A1 Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders |
| 01/03/2014 | WO2014000032A1 Phenyl amino pyrimidine bicyclic compounds and uses thereof |
| 01/03/2014 | CA2877923A1 Phenyl amino pyrimidine bicyclic compounds and uses thereof |
| 01/03/2014 | CA2877589A1 Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders |
| 01/02/2014 | US20140005213 Triazolopyridine compounds as pim kinase inhibitors |
| 01/02/2014 | US20140005174 Indole derivatives useful as ccr2 antagonists |
| 01/02/2014 | US20140005168 5-azaindazole compounds and methods of use |
| 01/02/2014 | US20140005167 Kinase inhibitors and method of treating cancer with same |
| 01/02/2014 | US20140005166 Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors |
| 01/02/2014 | US20140005164 Wnt pathway antagonists |
| 01/02/2014 | US20140005161 Phenyl amino pyrimidine bicyclic compounds and uses thereof |
| 01/02/2014 | US20140001442 Novel fused ring compound and organic light-emitting device including the same |
| 01/01/2014 | CN103492383A Materials for organic electroluminescent devices |
| 01/01/2014 | CN103484102A Rhodamine difunctional fluorescence probe and application thereof |
| 01/01/2014 | CN103483346A Demethylcantharidin imide derivative and preparation method and application thereof |
| 01/01/2014 | CN103483345A Phosphoinositide 3-kinase (P13K) inhibitor, pharmaceutical composition containing P13K inhibitor, and application of phosphoinositide kinase inhibitor and pharmaceutical composition |
| 12/31/2013 | US8618301 5-phenylpyrazolopyridine derivatives, preparation and therapeutic use thereof |
| 12/31/2013 | US8618156 Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 12/31/2013 | US8618128 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| 12/31/2013 | US8618124 Heterobifunctional polymeric bioconjugates |
| 12/31/2013 | US8618121 9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors |
| 12/31/2013 | US8618119 Fused cyanopyridines and the use thereof |
| 12/31/2013 | CA2705318C Inhibitors of human immunodeficiency virus replication |
| 12/31/2013 | CA2630562C Tricyclic compounds useful as inhibitors of kinases |
| 12/31/2013 | CA2629018C Aza-substituted spiro derivative |
| 12/31/2013 | CA2587489C Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 12/27/2013 | WO2013190481A1 Process for preparing asenapine and salts of intermediates thereof |
| 12/27/2013 | WO2013190300A1 Cyclohexane-1,2'-naphthalene-1',2"-imidazole compounds and their use as bace inhibitors |
| 12/27/2013 | WO2013189904A1 Pyranopyridone inhibitors of tankyrase |
| 12/27/2013 | WO2013189266A1 Compound of camptothecin and preparation and use thereof |
| 12/27/2013 | WO2013007361A9 Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 12/27/2013 | CA2875497A1 Cyclohexane-1,2'-naphthalene-1',2"-imidazole compounds and their use as bace inhibitors |
| 12/26/2013 | US20130345255 Trpv1 antagonists |
| 12/26/2013 | US20130345227 Pyrido [2, 3 - b] pyrazine derivatives and their therapeutical uses |
| 12/26/2013 | US20130345225 Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting parp |
| 12/26/2013 | US20130345219 Triazinone and diazinone derivatives useful as hsp90 inhibitors |
| 12/25/2013 | EP2675868A1 Compounds for electronic devices |
| 12/25/2013 | EP2675811A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 12/25/2013 | EP2675810A1 Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use |
| 12/25/2013 | EP2675791A1 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a) |
| 12/25/2013 | EP2675278A1 Methods for synthesizing molybdopterin precursor z derivatives |
| 12/25/2013 | EP2391627B1 Bicyclic pyrazolo-heterocycles |
| 12/25/2013 | EP2152670B1 Bridged six-membered ring compounds |
| 12/25/2013 | CN103476768A 6,5-heterocyclic propargylic alcohol compounds and uses therefor |
| 12/25/2013 | CN103476757A Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A) |
| 12/25/2013 | CN103467482A Condensed pyrimidine compound, and preparation method, intermediate, composition and application thereof |
| 12/25/2013 | CN103467450A Novel organic electroluminescent (EL) material and application thereof in devices |
| 12/25/2013 | CN103467449A Piperidine derivative, and preparation method and application thereof in preparation of halofuginone |
| 12/25/2013 | CN102617583B Method for quickly extracting and separating five types of alkaloids from macleaya cordata |
| 12/25/2013 | CN102285993B Tetrahydropyridine oxapicene derivative as well as preparation method and application thereof |
| 12/24/2013 | US8614324 Filamin A binding anti-inflammatory and analgesic |
| 12/24/2013 | US8614317 Sulfonamide derivatives of polycyclic dyes used for analytical applications |
| 12/24/2013 | US8614245 Crystalline (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine |
| 12/24/2013 | CA2585337C Trisubstituted thiophenes as progesterone receptor modulators |
| 12/24/2013 | CA2500822C Nodulisporic acid derivative spot-on formulations for combating parasites |
| 12/19/2013 | WO2013186109A1 2,3-dihydro-furo[2,3-c]pyridin-2-yl-piperidine derivatives, pharmaceutical compositions containing them and uses thereof |
| 12/19/2013 | US20130338364 Iodoarene derivative, method for manufacturing optically active spirolactone compound by using the same, and method for manufacturing optically active cycloadduct |
| 12/19/2013 | US20130338355 Process for preparing amorphous rifaxmin and the amorphous rifaximin thus obtained |
| 12/19/2013 | US20130338177 Spiro-Amino-Imidazolone and Spiro-Amino-Dihydro-Pyrimidinone Compounds as Beta-Secretase Modulators and Methods of Use |
| 12/19/2013 | US20130338139 Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-ones |